Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Sosne

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Expert Opinion on Biological Therapy|August 1, 2018
Thymosin beta 4 and the eye: the journey from bench to bedsideGabriel Sosne
Clinical Ophthalmology (Auckland, N.Z.)|June 10, 2015
Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) modelGabriel Sosne, George W Ousler
International Immunopharmacology|April 5, 2023
Thymosin beta 4: A potential novel adjunct treatment for bacterial keratitisGabriel Sosne, Elizabeth A Berger
Investigative Ophthalmology & Visual Science|August 5, 2015
Primary Mechanisms of Thymosin β4 Repair Activity in Dry Eye Disorders and Other Tissue InjuriesGabriel Sosne, Hynda K Kleinman
Experimental Eye Research|January 18, 2005
Plasminogen activator inhibitor-1 (PAI-1) stimulates human corneal epithelial cell adhesion and migration in vitroZhiyu Wang, Gabriel Sosne, Michelle Kurpakus-Wheater
American Journal of Ophthalmology Case Reports|December 21, 2017
Ocular dirofilariasis: Ophthalmic implication of climate change on vector-borne parasitesJoseph D Boss, Gabriel Sosne, Asheesh Tewari
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agentGabriel Sosne, Ping Qiu, Michelle Kurpakus-Wheater
Cornea|April 1, 2015
Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trialGabriel Sosne, Steven P Dunn, Chaesik Kim
Journal of Cellular Physiology|March 10, 2007
Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migrationPing Qiu, Michelle Kurpakus-Wheater, Gabriel Sosne
Investigative Ophthalmology & Visual Science|March 24, 2004
Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitroGabriel Sosne, Atif Siddiqi, Michelle Kurpakus-Wheater
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Expert Opinion on Biological Therapy|August 1, 2018
Thymosin beta 4 and the eye: the journey from bench to bedsideGabriel Sosne
Clinical Ophthalmology (Auckland, N.Z.)|June 10, 2015
Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) modelGabriel Sosne, George W Ousler
International Immunopharmacology|April 5, 2023
Thymosin beta 4: A potential novel adjunct treatment for bacterial keratitisGabriel Sosne, Elizabeth A Berger
Investigative Ophthalmology & Visual Science|August 5, 2015
Primary Mechanisms of Thymosin β4 Repair Activity in Dry Eye Disorders and Other Tissue InjuriesGabriel Sosne, Hynda K Kleinman
Experimental Eye Research|January 18, 2005
Plasminogen activator inhibitor-1 (PAI-1) stimulates human corneal epithelial cell adhesion and migration in vitroZhiyu Wang, Gabriel Sosne, Michelle Kurpakus-Wheater
American Journal of Ophthalmology Case Reports|December 21, 2017
Ocular dirofilariasis: Ophthalmic implication of climate change on vector-borne parasitesJoseph D Boss, Gabriel Sosne, Asheesh Tewari
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agentGabriel Sosne, Ping Qiu, Michelle Kurpakus-Wheater
Cornea|April 1, 2015
Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trialGabriel Sosne, Steven P Dunn, Chaesik Kim
Journal of Cellular Physiology|March 10, 2007
Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migrationPing Qiu, Michelle Kurpakus-Wheater, Gabriel Sosne
Investigative Ophthalmology & Visual Science|March 24, 2004
Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitroGabriel Sosne, Atif Siddiqi, Michelle Kurpakus-Wheater
Pageof 4